{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T18:45:41Z","timestamp":1760985941286,"version":"3.37.3"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T00:00:00Z","timestamp":1605139200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T00:00:00Z","timestamp":1605139200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"136 project award","award":["Not available"],"award-info":[{"award-number":["Not available"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n<jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Follow-up after curative surgery is increasingly recognized as an important component of breast cancer care. Although current guideline regulates the follow-ups, there are no relevant studies on the adherence to it in China. This study investigated the post-surgery follow-up and explored its association with patients, tumor and treatment characteristics.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>A total of 711 patients underwent surgical treatment in Shanxi Bethune Hospital from March 2012 to May 2018 were included in this study. Baseline sociodemographic, tumor, and treatment characteristics were obtained from the hospital electronic medical records. The post-surgery follow-up was reviewed and assessed from the patient\u2019s follow-up examination record. Factors associated with the first three-year follow up was evaluated using logistic regression analysis.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>The annual follow-up rate after surgery decreased gradually from 67.1% at the 1st year, 60.2% at the 3rd year to 51.9% at the 4th year, and 43.5% at the 5th year. Loss of follow-up during the first 3 years after surgery was significantly associated with older age (&gt;\u200965\u2009years), lower medical insurance coverage, axillary lymph node dissection, and less intensity of systemic treatment.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>A significant downtrend of annual follow-up rate for breast cancer survivors was confirmed in this study. Loss of follow-up within the first 3\u2009years after surgery was associated with both patient\u2019s characteristics and treatment. These results will provide evidence to help clinicians to develop tailored patient management after curative surgery.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12885-020-07600-y","type":"journal-article","created":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T09:05:56Z","timestamp":1605171956000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Adherence to post-surgery follow-up assessment and its association with sociodemographic and disease characteristics in patients with breast cancer in Central China"],"prefix":"10.1186","volume":"20","author":[{"given":"Ran","family":"Feng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingfeng","family":"Jing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9163-9453","authenticated-orcid":false,"given":"Jinnan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,11,12]]},"reference":[{"key":"7600_CR1","first-page":"315","volume":"41","author":"ML Zhang","year":"2019","unstructured":"Zhang ML, Peng P, Wu CX, Gong YM, Zhang SW, Chen WQ, et al. Report of breast cancer incidence and mortality in China registry regions,2008-2012. Zhonghua Zhong Liu Za Zhi. 2019;41:315\u201320.","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"key":"7600_CR2","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394\u2013424.","journal-title":"CA Cancer J Clin"},{"key":"7600_CR3","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3322\/caac.21338","volume":"66","author":"W Chen","year":"2016","unstructured":"Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66:115\u201332.","journal-title":"CA Cancer J Clin"},{"key":"7600_CR4","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1001\/jama.2018.19323","volume":"321","author":"AG Waks","year":"2019","unstructured":"Waks AG, Winer EP. Breast cancer treatment: a review. JAMA. 2019;321:288\u2013300.","journal-title":"JAMA."},{"key":"7600_CR5","unstructured":"Clinical Practice Guidelines in Oncology. Breast cancer \u2013 V.3: National Comprehensive Cancer Network; 2019. https:\/\/www.nccn.org\/professionals\/development.aspx. Accessed 25 Nov 2019."},{"key":"7600_CR6","first-page":"29","volume":"41","author":"F Ma","year":"2019","unstructured":"Ma F, Xu BH, Shao ZM, et al. Comprehensive management guideline for breast cancer follow-up and concomitant diseases. Zhonghua Zhong Liu Za Zhi. 2019;41:29\u201341.","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"key":"7600_CR7","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1200\/JCO.2015.62.3504","volume":"34","author":"M Colleoni","year":"2016","unstructured":"Colleoni M, Sun Z, Price KN, Karlsson P, Forbes JF, Th\u00fcrlimann B, et al. Annual Hazard rates of recurrence for breast cancer during 24 years of follow-up: results from the international breast cancer study group trials I to V. J Clin Oncol. 2016;34:927\u201335.","journal-title":"J Clin Oncol"},{"key":"7600_CR8","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3390\/ijerph17010277","volume":"17","author":"J Liu","year":"2019","unstructured":"Liu J, Jiang Y, Qian M, Lv L, Ying X. The improved effects of a multidisciplinary team on the survival of breast cancer patients: experiences from China. Int J Environ Res Public Health. 2019;17:277.","journal-title":"Int J Environ Res Public Health"},{"key":"7600_CR9","doi-asserted-by":"publisher","unstructured":"Sumit KS, Mayumi N, Benjamin JL. Examining aspects of successful community-based programs promoting cancer screening uptake to reduce cancer health disparity: a systematic review. Prev Med. 2020. https:\/\/doi.org\/10.1016\/j.ypmed.2020.106242.","DOI":"10.1016\/j.ypmed.2020.106242"},{"key":"7600_CR10","doi-asserted-by":"publisher","unstructured":"Emma R, Amanda EH, Anna C, Katy S, Alison R, Vibe HP. Telephone interventions for symptom management in adults with cancer. Cochrane Database Syst Rev. 2020. https:\/\/doi.org\/10.1002\/14651858.CD007568.pub2.","DOI":"10.1002\/14651858.CD007568.pub2"},{"key":"7600_CR11","doi-asserted-by":"publisher","unstructured":"Natoli C, Brocco D, Sperduti I, Nuzzo A, Tinari N, Tursi MD, et al. Breast cancer \"tailored follow-up\" in Italian oncology units: a web-based survey. PLoS One. 2014. https:\/\/doi.org\/10.1371\/journal.pone.0094063.","DOI":"10.1371\/journal.pone.0094063"},{"key":"7600_CR12","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1097\/COC.0000000000000408","volume":"41","author":"A Gill","year":"2018","unstructured":"Gill A, Gosain R, Bhandari S, Gosain R, Gill G, Abraham J, et al. \u201cLost to follow-up\u201d among adult cancer survivors. Am J Clin Oncol. 2018;41:1024\u20137.","journal-title":"Am J Clin Oncol"},{"key":"7600_CR13","first-page":"82","volume-title":"Model-building strategies and methods for logistic regression","author":"D Hosmer","year":"1989","unstructured":"Hosmer D, Lemeshow S. In: Hosmer D, Lemeshow S, editors. Model-building strategies and methods for logistic regression. New York City: Wiley; 1989. p. 82\u2013126."},{"key":"7600_CR14","doi-asserted-by":"publisher","unstructured":"Lu W, Jansen L, Schaapveld M, Baas PC, Wiggers T, Bock GHD. Underuse of long-term routine hospital follow-up care in patients with a history of breast cancer? BMC Cancer. 2011. https:\/\/doi.org\/10.1186\/1471-2407-11-279.","DOI":"10.1186\/1471-2407-11-279"},{"key":"7600_CR15","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1200\/JOP.200009","volume":"6","author":"E Grunfeld","year":"2010","unstructured":"Grunfeld E, Hodgson DC, Giudice ME, Moineddin R. Population-based longitudinal study of follow-up Care for Breast Cancer Survivors. J Oncol Pract. 2010;6:174\u201381.","journal-title":"J Oncol Pract"},{"key":"7600_CR16","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1097\/00005650-200003000-00005","volume":"38","author":"MM Schapira","year":"2010","unstructured":"Schapira MM, McAuliffe TL, Nattinger AB. Underutilization of mammography in older breast cancer survivors. Med Care. 2010;38:281\u20139.","journal-title":"Med Care"},{"key":"7600_CR17","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1186\/s12885-019-5882-z","volume":"19","author":"LM Mary","year":"2019","unstructured":"Mary LM, Patti AG, Kathleen D, Cynthia K, Li J, Marlo W, et al. Adherence to quality breast cancer survivorship care in four Canadian provinces: a CanIMPACT retrospective cohort study. BMC Cancer. 2019;19:659\u201370.","journal-title":"BMC Cancer"},{"key":"7600_CR18","doi-asserted-by":"publisher","unstructured":"Richard GM. How to include patient-reported outcome measures in clinical trials. Curr Osteoporos Rep. 2020. https:\/\/doi.org\/10.1007\/s11914-020-00611-5.","DOI":"10.1007\/s11914-020-00611-5"},{"key":"7600_CR19","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1016\/j.jval.2019.04.1927","volume":"22","author":"SEE Laurentine","year":"2019","unstructured":"Laurentine SEE, Arvind O, Lisanne MV, Hester FL, Linetta BK, Cornelis V, et al. Implementing patient-reported outcome measures in clinical breast cancer care: a systematic review. Value Health. 2019;22:1197\u2013226.","journal-title":"Value Health"},{"key":"7600_CR20","doi-asserted-by":"publisher","first-page":"4128","DOI":"10.1245\/s10434-013-3170-8","volume":"20","author":"HB Neuman","year":"2013","unstructured":"Neuman HB, Weiss JM, Schrag D, Ronk K, Havlena J, LoConte NK, et al. Patient demographic and tumor characteristics influencing oncologist follow-up frequency in older breast cancer survivors. Ann Surg Oncol. 2013;20:4128\u201336.","journal-title":"Ann Surg Oncol"},{"key":"7600_CR21","doi-asserted-by":"publisher","unstructured":"Onega T, Weiss J, Diflorio R, Mackenzie T, Goodrich M, Poplack S. Evaluating surveillance breast imaging and biopsy in older breast cancer survivors. Int J Breast Cancer. 2012. https:\/\/doi.org\/10.1155\/2012\/347646.","DOI":"10.1155\/2012\/347646"},{"key":"7600_CR22","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.2147\/PPA.S172223","volume":"12","author":"X Wang","year":"2018","unstructured":"Wang X, Xu B, Liang H, Jiang S, Tan H, Wang X, et al. Distribution characteristics and factors influencing oral warfarin adherence in patients after heart valve replacement. Patient Prefer Adherence. 2018;12:1641\u20138.","journal-title":"Patient Prefer Adherence"},{"key":"7600_CR23","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1136\/ejhpharm-2018-001725","volume":"26","author":"NC Wilhelmsen","year":"2019","unstructured":"Wilhelmsen NC, Eriksson T. Medication adherence interventions and outcomes: an overview of systematic reviews. Eur J Hosp Pharm. 2019;26:187\u201392.","journal-title":"Eur J Hosp Pharm"},{"key":"7600_CR24","first-page":"80","volume":"27","author":"SY Zafar","year":"2013","unstructured":"Zafar SY, Abernethy AP. Financial toxicity, part I: a new name for a growing problem. Oncology (Williston Park). 2013;27:80\u20131,149.","journal-title":"Oncology (Williston Park)"},{"key":"7600_CR25","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s10549-020-05632-3","volume":"181","author":"JF Jing","year":"2020","unstructured":"Jing JF, Feng R, Zhang XJ, Li M, Gao J. Financial toxicity and its associated patient and cancer factors among women with breast cancer: a single-center analysis of low-middle income region in China. Breast Cancer Res Treat. 2020;181:435\u201343.","journal-title":"Breast Cancer Res Treat"},{"key":"7600_CR26","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1200\/JCO.2013.53.0956","volume":"32","author":"R Jagsi","year":"2014","unstructured":"Jagsi R, Pottow JA, Griffith KA, Bradley C, Hamilton AS, Graff J, et al. Long-term financial burden of breast cancer: experiences of a diverse cohort of survivors identified through population-based registries. J Clin Oncol. 2014;32:1269\u201376.","journal-title":"J Clin Oncol"},{"key":"7600_CR27","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1634\/theoncologist.2014-0117","volume":"19","author":"B Irwin","year":"2014","unstructured":"Irwin B, Kimmick G, Altomare I, Marcom PK, Houck K, Zafar SY, et al. Patient experience and attitudes toward addressing the cost of breast cancer care. Oncologist. 2014;19:1135\u201340.","journal-title":"Oncologist."},{"key":"7600_CR28","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1093\/ije\/dyi275","volume":"35","author":"LA Jackson","year":"2006","unstructured":"Jackson LA, Nelson JC, Benson P, Neuzil KM, Reid RJ, Psaty BM, et al. Functional status is a confounder of the association of influenza vaccine and risk of all-cause mortality in seniors. Int J Epidemiol. 2006;35:345\u201352.","journal-title":"Int J Epidemiol"},{"key":"7600_CR29","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1200\/JCO.2005.02.4174","volume":"24","author":"NL Keating","year":"2006","unstructured":"Keating NL, Landrum MB, Guadagnoli E, Winer EP, Ayanian JZ. Factors related to underuse of surveillance mammography among breast cancer survivors. J Clin Oncol. 2006;24:85\u201394.","journal-title":"J Clin Oncol"},{"key":"7600_CR30","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.maturitas.2016.06.014","volume":"91","author":"AJ Berendsen","year":"2016","unstructured":"Berendsen AJ, Roorda C, Jansen L, de Bock GH. Patients' beliefs about the aims of breast cancer follow-up: a qualitative study. Maturitas. 2016;91:140\u20134.","journal-title":"Maturitas."},{"key":"7600_CR31","doi-asserted-by":"publisher","first-page":"126","DOI":"10.3747\/co.25.3838","volume":"25","author":"K Enright","year":"2018","unstructured":"Enright K, Desai T, Sutradhar R, Gonzalez A, Powis M, Taback N, et al. Factors associated with imaging in patients with early breast cancer after initial treatment. Curr Oncol. 2018;25:126\u201332.","journal-title":"Curr Oncol"},{"key":"7600_CR32","doi-asserted-by":"publisher","unstructured":"Robinson B, Dijkstra B, Davey V, Tomlinson S, Frampton C. Adherence to adjuvant endocrine therapy in Christchurch women with early breast cancer. Clin Oncol (R Coll Radiol). 2018. https:\/\/doi.org\/10.1016\/j.clon.2017.10.015.","DOI":"10.1016\/j.clon.2017.10.015"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-020-07600-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-020-07600-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-020-07600-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T09:07:00Z","timestamp":1605172020000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-020-07600-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,12]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["7600"],"URL":"https:\/\/doi.org\/10.1186\/s12885-020-07600-y","relation":{},"ISSN":["1471-2407"],"issn-type":[{"type":"electronic","value":"1471-2407"}],"subject":[],"published":{"date-parts":[[2020,11,12]]},"assertion":[{"value":"3 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The research has been approved by Ethics Committee of Shanxi Bethune Hospital (No: YXLL-2019-130). Individual consent to participate was waived due to the nature of administrative registry data and participant privacy is protected through the use of non-identifiable data and by only reporting aggregated data.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1098"}}